Sight Sciences details 2026 annual meeting votes

Sight Sciences, Inc. reported the results of its annual stockholder meeting held on June 4, 2026.

Accepted by SEC EDGAR 06/05/2026 - 04:06 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Sight Sciences, Inc. reported the results of its annual stockholder meeting held on June 4, 2026. A total of 41,456,258 shares were present or represented by proxy, which was about 76.2% of the 54,403,542 shares outstanding as of the April 8, 2026 record date.

Stockholders elected Class II directors Gerhard Burbach and Staffan Encrantz to serve until the 2029 annual meeting or until their successors are elected. They also ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. No other matters were brought for a vote.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Key Figures

Shares outstanding: 54,403,542 shares Shares represented: 41,456,258 shares Vote for Burbach: 24,961,185 for / 2,877,580 withheld +3 more

6 metrics

Shares outstanding 54,403,542 shares Common stock entitled to vote as of April 8, 2026 record date

Shares represented 41,456,258 shares Shares present or by proxy at June 4, 2026 annual meeting (~76.2%)

Vote for Burbach 24,961,185 for / 2,877,580 withheld Election of Class II director Gerhard Burbach; 13,617,493 broker non-votes

Vote for Encrantz 23,901,624 for / 3,937,141 withheld Election of Class II director Staffan Encrantz; 13,617,493 broker non-votes

Auditor ratification votes 41,059,471 for / 7,892 against Ratification of Deloitte & Touche LLP; 388,895 abstain, no broker non-votes

Meeting date June 4, 2026 Date of annual meeting of stockholders

Key Terms

record date, broker non-votes, independent registered public accounting firm, Class II directors, +1 more

5 terms

record date financial

"the record date for the Annual Meeting (the “Record Date”)"

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

broker non-votes financial

"2,877,580 | | | | 13,617,493 | Broker Non-Votes"

Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

independent registered public accounting firm financial

"as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026"

An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

Class II directors financial

"Election of two Class II directors to serve as directors of the Company"

Annual Meeting financial

"held its annual meeting of stockholders (the “Annual Meeting”)"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sight Sciences (SGHT) stockholders vote on at the 2026 annual meeting?

Stockholders voted on electing two Class II directors and ratifying Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. No other proposals or matters were presented for stockholder action at this meeting.

How many Sight Sciences (SGHT) shares were eligible and represented at the 2026 annual meeting?

There were 54,403,542 common shares outstanding and entitled to vote as of the April 8, 2026 record date. At the meeting, 41,456,258 shares were present or represented by proxy, representing approximately 76.2% of the shares outstanding on the record date.

Who was elected to the Sight Sciences (SGHT) board at the 2026 annual meeting?

Stockholders elected Gerhard Burbach and Staffan Encrantz as Class II directors. They will serve until the annual meeting of stockholders to be held in 2029, or until their successors are duly elected and qualified, or their earlier death, resignation, or removal.

What were the vote totals for Sight Sciences (SGHT) director elections in 2026?

For Gerhard Burbach, 24,961,185 votes were cast for and 2,877,580 withheld, with 13,617,493 broker non-votes. For Staffan Encrantz, 23,901,624 votes were cast for and 3,937,141 withheld, with 13,617,493 broker non-votes recorded on this proposal.

Did Sight Sciences (SGHT) stockholders ratify Deloitte & Touche LLP in 2026?

Yes. Stockholders ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The vote was 41,059,471 shares for, 7,892 against, and 388,895 abstaining, with no broker non-votes reported on this auditor proposal.

Were any other matters considered at the 2026 Sight Sciences (SGHT) annual meeting?

No. The company states that no other matters were presented for consideration or stockholder action at the annual meeting beyond electing two Class II directors and ratifying the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

0001531177false00015311772026-06-042026-06-04

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 4, 2026

Sight Sciences, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-40587	80-0625749
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
4040 Campbell Avenue Suite 100
Menlo Park, California				94025
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 877 266-1144

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value per share		SGHT		Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 4, 2026, Sight Sciences, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). There were 54,403,542 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), outstanding and entitled to vote at the Annual Meeting at the close of business on April 8, 2026, the record date for the Annual Meeting (the “Record Date”). At the Annual Meeting, 41,456,258 shares of Common Stock were present virtually or represented by proxy, representing approximately 76.2% of the Common Stock outstanding on the Record Date.

Set forth below are the voting results for the proposals considered and voted upon at the Annual Meeting, each of which are described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 22, 2026.

Proposal 1 – Election of two Class II directors to serve as directors of the Company until the annual meeting of stockholders to be held in 2029, or until each such director’s respective successor has been duly elected and qualified, or until each such director’s earlier death, resignation or removal.

Name of Director		For				Withheld				Broker Non-Votes
Gerhard Burbach			24,961,185				2,877,580				13,617,493
Staffan Encrantz			23,901,624				3,937,141				13,617,493

Proposal 2 – Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

For				Against				Abstain				Broker Non-Votes
	41,059,471				7,892				388,895			-

Based on the foregoing votes, Gerhard Burbach and Staffan Encrantz were elected as Class II directors, and the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was duly ratified.

No other matters were presented for consideration or stockholder action at the Annual Meeting.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Sight Sciences, Inc.
Date:	June 5, 2026	By:	/s/ James Rodberg
			James Rodberg Chief Financial Officer (Principal Financial and Accounting Officer)

Filing Exhibits & Attachments

1 document

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 32.4 KB